Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2013
11/21/2013US20130309272 Compounds for inflammation and immune-related uses
11/21/2013US20130309191 Compounds for the treatment of clostridium difficile-associated disease
11/20/2013EP2664618A2 Chemokine receptor modulators
11/20/2013EP2664617A1 Method of making a 2,6-diaryl piperidine derivative
11/20/2013EP2664616A1 Hydantoin and thiohydantoin derivatives as antiviral drugs
11/20/2013EP2663574A2 Inhibitors of retroviral replication
11/20/2013EP2663555A2 Substituted benzoazepines as toll-like receptor modulators
11/20/2013EP2663554A1 Carbazole end capped bipyridine compounds and process for preparation thereof
11/20/2013EP2663553A2 Quinoline and isoquinoline compounds and methods of use thereof
11/20/2013EP2663550A2 Substituted benzoazepines as toll-like receptor modulators
11/20/2013EP2663306A1 Polymorphs of dexlansoprazole salts
11/20/2013EP2491024B1 Substituted n-phenyl-1-(4-pyridinyl)-1h-pyrazol-3-amines
11/20/2013EP2414348B1 Bicyclic piperidine and piperazine derivatives as gpcr modulators for the treatment of obesity, diabetes and other metabolic disorders
11/20/2013EP2407451B1 N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
11/20/2013EP2403832B1 N-(hetero)aryl,2-(hetero)aryl-substituted acetamides for use as wnt signaling modulators
11/20/2013EP2346834B1 3-amino-indazole or 3-amino-4,5,6,7-tetrahydro-indazole derivatives
11/20/2013EP2307387B1 Novel heterocyclyl compounds for treatment of cardiovascular disease
11/20/2013EP2300452B1 5-[5-[2-(3,5-bis(trifluoromethyl)phenyl)-2-methylpropanoylmethylamino]-4-(4-fluoro-2-methylphenyl)]-2-pyridinyl-2-alkyl-prolinamide as nk1 receptor antagonists
11/20/2013EP2265599B1 Crystal form of phenylaminopyrimidine derivative
11/20/2013EP2251337B1 Dihydropyridine calcium antagonist compounds, preparation methods and medical uses thereof
11/20/2013EP2091943B1 Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors
11/20/2013EP2007747B1 Process for preparing heterocyclic derivatives
11/20/2013EP1951708B1 Piperazine derivative useful as a ccr5 antagonist
11/20/2013EP1809624B1 Pyrimidine sulphonamide derivatives as chemokine receptor modulators
11/20/2013EP1765805B1 Cgrp receptor antagonists
11/20/2013EP1709009B1 6-amino-5-cyano-pyrimidine-4-ones used for improving perception, power of concentration, learning efficiency, and/or memory power
11/20/2013EP1572199B1 Pyrazole derivatives modulators of hepatocyte growth factor (scatter factor) activity
11/20/2013CN103403582A Curable coloring composition, color filter and manufacturing method for same, liquid crystal display device, solid-state image-capturing device, and dye compound.
11/20/2013CN103403018A Trypsin-like serine protease inhibitors, their preparation and use as selective inhibitors of the clotting factors IIa and Xa
11/20/2013CN103402997A Diaminopyrimidine derivatives and processes for the preparation thereof
11/20/2013CN103402996A Indole compounds or analogues thereof useful for the treatment of age-related macular degeneration (AMD)
11/20/2013CN103402995A Novel indole or indazole derivative or salt thereof
11/20/2013CN103402987A 6-amino-2-phenylamino-1H-benzimidazole-5-carboxamide- derivatives and their use as microsomal prostaglandin E2 synthase-1 inhibitors
11/20/2013CN103402985A Microbiocidal pyrazole derivatives
11/20/2013CN103402984A Novel kinase inhibitors
11/20/2013CN103402983A (Pyridin-4-yl)benzylamides as allosteric modulators of alpha 7 NACHR
11/20/2013CN103402979A Chemical compounds
11/20/2013CN103402977A Ingenol-3-acylates III and ingenol-3-carbamates
11/20/2013CN103402517A Method of treatment with BRAF inhibitor
11/20/2013CN103402515A Sgc stimulators
11/20/2013CN103396412A Modifier of 5-HT2A serotonin receptor
11/20/2013CN103396409A Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
11/20/2013CN103396405A Benzimidazole-4-formamide derivate with PARP (poly-ADP-ribose polymerase) inhibiting effect
11/20/2013CN103396404A Compound using triphenylpyrimidine as core as well as preparation method and application thereof
11/20/2013CN103396403A Insecticidal compound
11/20/2013CN103396402A Substituted aminoindanes and analogs thereof, and pharmaceutical use thereof
11/20/2013CN103396401A Method for preparing esomeprazole
11/20/2013CN103396400A Pyrazole amide compounds, and preparation method and application thereof
11/20/2013CN103396399A Nitrogenated aromatic 6-membered ring derivative, and pharmaceutical agent comprising same
11/20/2013CN103396398A Prokineticin 1 receptor antagonists
11/20/2013CN103396397A Lenalidomide derivative and use thereof as medicine
11/20/2013CN103396396A Amido alkyl acyl clinafloxacin and application thereof
11/20/2013CN103396395A Method for synthesizing N-(5-nitryl-2-methyl pyridyl-3-)-4-(3-pyridyl)-2-pyrilamine and intermediate thereof
11/20/2013CN103396359A Iminipyridine derivatives and uses thereof as microbiocides
11/20/2013CN103393695A Methods and compositions for treatment and management of multiple myeloma
11/20/2013CN103393681A Methodand composition for treatment and management of multiple myeloma
11/20/2013CN102731479B Organic ligand, rare earth organic fluorescent probe material thereof and preparation method thereof
11/20/2013CN102633717B N-acetyl-quinoline-2 (1H) ketone compounds as well as preparation method and application thereof
11/20/2013CN102617554B Two-photon fluorescent probe taking naphthaline as matrix as well as preparation method and application thereof
11/20/2013CN102421771B Pyridinone amide derivatives, preparation methods and medical uses thereof
11/20/2013CN102234265B Lansoprazole compound
11/20/2013CN102015680B New substituted indolin-2-one derivatives and use thereof as p38 mitogen-activated kinase inhibitors
11/20/2013CN101801956B Method for modulating GPR119 G protein-coupled receptor and selected compounds
11/20/2013CN101723932B Nitropyridine ethylenimine compound, medicinal composition, preparation method and application thereof
11/20/2013CN101652357B Method for producing quinolone carboxylic acid derivative
11/20/2013CN101605779B Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
11/20/2013CN101553482B Kinase inhibitor compounds
11/20/2013CN101506196B Compound that can inhibit UBC13-UEV interactions, pharmaceutical compositions and therapeutic uses
11/19/2013US8586754 BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
11/19/2013US8586753 Process for the preparation of 1-alkyl and 1-aryl-5-pyrazolecarboxylic acid derivatives
11/19/2013US8586752 Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same
11/19/2013US8586751 Nicotinamide compounds useful as kinase modulators
11/19/2013US8586748 2-sulfonylamino-4-heteroaryl butyramide antagonists of CCR10
11/19/2013US8586747 3,3-dimethyl tetrahydroquinoline derivatives
11/19/2013US8586737 Process of a quaternary ammonium salt using phosphate
11/19/2013US8586613 Pyridinium and quinolinium derivatives
11/19/2013US8586609 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament
11/19/2013US8586600 Heterocyclic compounds and uses thereof
11/19/2013US8586593 Insecticidal compounds
11/19/2013US8586591 Aminopyrazine derivative and medicine
11/19/2013US8586588 Aryl pyridazinone derivatives and their use as H3 receptor ligands
11/19/2013US8586577 Diazepane acetamide derivatives as selective 11B-HSD1 inhibitors
11/19/2013US8586573 N-(Aminoheteroaryl)-1H-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof
11/19/2013US8586571 Heterocyclic compound
11/19/2013CA2746307C Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors
11/19/2013CA2707418C Inhibitors of human immunodeficiency virus replication
11/19/2013CA2633624C 3,5-substituted piperidine compounds as renin inhibitors
11/19/2013CA2618340C Piperidine and piperazine derivatives as p2x3 antagonists
11/14/2013WO2013170186A1 Carbazole-containing sulfonamides as cryptochrome modulators
11/14/2013WO2013170115A1 Pyridazine and pyridine derivatives as nampt inhibitors
11/14/2013WO2013170113A1 Nampt inhibitors
11/14/2013WO2013169907A1 Alpha 7 nicotinic acetylcholine allosteric modulators, their derivatives and uses thereof
11/14/2013WO2013168967A1 Diaminoaryl derivatives substituted by carbamate and pesticidal composition containing same
11/14/2013WO2013168709A1 Organic thin film solar cell, monomers and organic semiconductor material composition used in organic thin film solar cell
11/14/2013WO2013168688A1 Organic electroluminescence element, illumination device, and display device
11/14/2013WO2013168025A1 Compositions and methods for treatment of blood clotting disorders
11/14/2013WO2013167698A1 Substituted cycloalkenopyrazoles as bub1 inhibitors for the treatment of cancer
11/14/2013WO2013167495A1 Bicyclically substituted uracils and the use thereof
11/14/2013WO2013166952A1 Substituted aminoquinazolines useful as kinases inhibitors
11/14/2013WO2013079586A4 Carboxamide-substituted heteroaryl-pyrazoles and the use thereof
1 ... 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 ... 1080